Skip to main content

COVID Vaccine Mistrust Levels Aren't Budging, Study Finds

Medically reviewed by Carmen Pope, BPharm. Last updated on Nov 6, 2024.

By Dennis Thompson HealthDay Reporter

WEDNESDAY, Nov. 6, 2024 -- More than a third of Americans continue to express mistrust in the science behind COVID vaccines, a new study finds.

This level of mistrust has remained relatively consistent, expressed by 36% of people in 2021, 33% in 2022 and 36% in 2023.

People who lost a family member or close friend to COVID were significantly more likely to trust vaccine science and accept vaccination, results showed.

For example, those who experienced a loss within the past year were nearly four times more likely to trust vaccine experts, compared to those who didn’t lose someone, researchers found.

"Our findings underscore the critical role of trust in science during public health crises,” said lead researcher Trenton White, a postdoctoral fellow with the Barcelona Institute for Global Health. “The fact that personal experiences of loss due to COVID-19 was associated with trust levels highlights the need for public health communications to be sensitive to the emotional impact of the pandemic."

Overall, vaccine acceptance tended to be higher in men, people with college degrees and higher-income families.

In the future, public health officials should consider the diverse backgrounds of the U.S. population and cater messages to effectively build and maintain trust in science, the researchers said.

“This research provides valuable insights for policymakers and health communicators as they continue to navigate the ongoing challenge of global vaccine hesitancy,” senior researcher Ayman El-Mohandes, dean of the CUNY Graduate School of Public Health and Health Policy, said in a CUNY news release.

The new study was published Nov. 2 in the journal Vaccine: X.

Sources

  • CUNY Graduate School of Public Health and Health Policy, news release, Nov. 4, 2024

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2025 HealthDay. All rights reserved.

Posted November 2024

Further Support and Information on COVID-19

Read this next

Medicaid 'Unwinding' Caused Drop In Insurance Coverage Among Working-Age Adults

WEDNESDAY, April 30, 2025 -- The “unwinding” of Medicaid that occurred after the end of the COVID-19 pandemic has left more working-age Americans without health...

United States Seeing Uptick in Whooping Cough Cases

MONDAY, April 28, 2025 -- As case numbers rise, public health officials are warning of yet another difficult year of battling pertussis infections, according to a report from the...

HHS Announces Plans to Pay Moderna $176 Million for mRNA Flu Vaccine

FRIDAY, April 25, 2025 -- On Tuesday, the U.S. Department of Health and Human Services announced that the government will invest $176 million in Moderna to expedite the creation...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.